New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 28, 2020 - The FDA approved Sun Pharmaceutical’s Bynfezia (octreotide acetate) pen.
Download PDF
Return to publications
